News Highlights

 

2011 FDA authorized JN's IND for conducting Conjugated Meningococcal vaccine human trials in Hanford, California

 

2011 Neurology scientists bags Stroke Grant Award - US Govt.

 

2006-2011 Meningitis vaccine for Disease outbreaks in India & sub-Saharan

 

CONFERENCES

 

Mr. Hankins & Dr.Reddy at NG Pharma conf in Amsterdam

 

Dr. Orten & Dr. Reddy - at CNS World Summit

 

 
 
 
JN researchers finding answers for Transient Ischemic stroke, Ischemic stroke & Alzheimer's.

  Promising New Study Attempts to Perfect a Genital Herpes Vaccine

Welcome to JN-International Medical Corporation, a U.S. based private  biopharmaceutical corporation, has been developing vaccines for infectious disease and neurological disorders. Emphasis on our 20-years of basic research combined with an applied focus on specific medical needs was instrumental to success and growth of this corporation. The style of JN, our new corporate website, reflects our values and gives information on our principle business areas. So happy reading!

 

Scientific Discovery since 1998 

Flag of the United States.svg    American Exports

 

 

To Saharan Africa, Middle East, Latin America and Asia through our subsidiaries and distributions. Export product:

 

 

 

VaccinesDiagnostics

 

 

 

 

 

The corporation 

JNI Medical Corp - Admin Building
 

Do you Know? JN is the 3rd BioPharma, developed patented Meningococcal meningitis serogroups A/C/Y/W135 diphtheria toxoid conjugate vaccine (NmVac-4dt) which is now human phase. JN also developing vaccine for Genital Herpes and therapeutic Ischemic Stroke. Inc5000 Fastest Growing Company

 

 

Meningococcal VACCINE Meningococcal meningitis vaccine for children
 

NmVac4-A/C/Y/W-135-DT “NmVac-4dt is among the most complex biotech or biologic products of JN. It’s a combination vaccine that contains four 4 different vaccines in one and can be used with any combination by the geographic prevalence of the disease causing serogroup A, C, Y &W-135.”

 

 

Neurological THERAPIES

 

Research JN neurology team has developed Biomarkers and Therapeutics to intervene TIA / Stroke, Epilepsy, Alzheimer's.

  1. Vaccine saves mice

  2. Auto Antibodies NEWS

  3. Biomarkers

  4. Stroke therapeutic

GLOBAL HEALTH

 

Filled Commitment

 

 

 

US President Malaria Initiative & JN International Medical Corporation

 

© 1998 JN-International, Inc. Oakland, Nebraska 68045, USA . BYLAWS TERMS OF USE LEGAL DISCLAIMER